[HENGYUAN] YoY Annualized Quarter Result on 31-Mar-2023 [#1]

Stock
[HENGYUAN] HENGYUAN REFINING COMPANY BERHAD
Announcement Date
29-May-2023
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2023
Quarter
31-Mar-2023 [#1]
Profit Trend
QoQ- -205.87%
YoY- -354.01%
Quarter Report
Latest QR
Upcoming QR
HENGYUAN's Result
HENGYUAN's Financial Summary
View:
Show?
Annualized Quarter Result
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
Revenue 19,949,748 17,529,692 19,813,032 8,791,568 10,197,388 11,839,828 12,243,136 8.46%
PBT 5,440 -722,452 341,112 134,288 -494,532 162,768 435,212 -51.79%
Tax -768 240,280 -151,288 -69,056 -1,960 -76,480 -87,980 -54.59%
NP 4,672 -482,172 189,824 65,232 -496,492 86,288 347,232 -51.19%
-
NP to SH 4,672 -482,172 189,824 65,232 -496,492 86,288 347,232 -51.19%
-
Tax Rate 14.12% - 44.35% 51.42% - 46.99% 20.22% -
Total Cost 19,945,076 18,011,864 19,623,208 8,726,336 10,693,880 11,753,540 11,895,904 8.98%
-
Net Worth 1,485,360 1,674,959 1,988,490 2,143,349 2,232,540 1,971,540 1,785,930 -3.02%
Dividend
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
Div - - - - - - - -
Div Payout % - - - - - - - -
Equity
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
Net Worth 1,485,360 1,674,959 1,988,490 2,143,349 2,232,540 1,971,540 1,785,930 -3.02%
NOSH 300,000 300,000 300,000 300,000 300,000 300,000 300,000 0.00%
Ratio Analysis
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
NP Margin 0.02% -2.75% 0.96% 0.74% -4.87% 0.73% 2.84% -
ROE 0.31% -28.79% 9.55% 3.04% -22.24% 4.38% 19.44% -
Per Share
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
RPS 6,649.92 5,843.23 6,604.34 2,930.52 3,399.13 3,946.61 4,081.05 8.46%
EPS 1.56 -160.72 63.28 21.76 -165.48 28.76 115.76 -51.18%
DPS 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
NAPS 4.9512 5.5832 6.6283 7.1445 7.4418 6.5718 5.9531 -3.02%
Adjusted Per Share Value based on latest NOSH - 300,000
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
RPS 6,649.92 5,843.23 6,604.34 2,930.52 3,399.13 3,946.61 4,081.05 8.46%
EPS 1.56 -160.72 63.28 21.76 -165.48 28.76 115.76 -51.18%
DPS 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
NAPS 4.9512 5.5832 6.6283 7.1445 7.4418 6.5718 5.9531 -3.02%
Price Multiplier on Financial Quarter End Date
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
Date 29/03/24 31/03/23 31/03/22 31/03/21 31/03/20 29/03/19 30/03/18 -
Price 3.19 3.44 3.97 5.20 2.48 5.83 7.65 -
P/RPS 0.05 0.06 0.06 0.18 0.07 0.15 0.19 -19.93%
P/EPS 204.84 -2.14 6.27 23.91 -1.50 20.27 6.61 77.13%
EY 0.49 -46.72 15.94 4.18 -66.73 4.93 15.13 -43.51%
DY 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
P/NAPS 0.64 0.62 0.60 0.73 0.33 0.89 1.29 -11.01%
Price Multiplier on Announcement Date
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
Date 24/05/24 29/05/23 30/05/22 28/05/21 16/06/20 24/05/19 21/05/18 -
Price 2.89 3.27 6.70 5.68 3.62 5.78 8.29 -
P/RPS 0.04 0.06 0.10 0.19 0.11 0.15 0.20 -23.50%
P/EPS 185.57 -2.03 10.59 26.12 -2.19 20.10 7.16 71.94%
EY 0.54 -49.15 9.44 3.83 -45.72 4.98 13.96 -41.81%
DY 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
P/NAPS 0.58 0.59 1.01 0.80 0.49 0.88 1.39 -13.54%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment